Patients covered by government insurance programs, such as Medicare and Medicaid, are not eligible for this offer
Anyone considering GLP-1 therapy should consult a healthcare provider about FDA-approved options
The wildly popular obesity drugs Wegovy developed by Novo Nordisk and Zepbound by Eli Lilly are known as GLP-1 receptor agonists, which mimic the activity of a hormone that slows digestion and helps people feel full for longer
Description Additional information Description Modified GRF (1-29) (GHRH) 2MG VIAL **Important Information: Each peptide comes lyophilized/freeze-dried and must be reconstituted with Bacteriostatic Water in order to be dispensable in liquid form
Itchiness: The rash is often itchy, which can cause discomfort
Topics Covered Current and potential uses for Ozempic and GLP-1 (6:42) Common side effects from Ozempic (8:48) Understanding the obesity and chronic disease crisis (9:33) Long-term risks associated with Ozempic (14:47) Combatting the idea that obesity is genetic (17:54) Can you be healthy at any size